EUVIMEDEUVIMED entdecken
Multizentrische Studie

Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study

Jorge R Georgakopoulos, Dropen Sheka, Brian Rankin, Khalad Maliyar, Alexander Rimke, Vimal H Prajapati, Jensen Yeung

Journal of the American Academy of Dermatology · 2023

DOI: 10.1016/j.jaad.2023.08.059 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Academy of Dermatology, 2023. Verfasst von Jorge R Georgakopoulos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHumansAdultRetrospective StudiesAntibodies, Monoclonal, HumanizedTreatment OutcomeSeverity of Illness IndexHeterocyclic Compounds, 3-Ring

Stichwörter der Autor:innen

JAK inhibitoratopic dermatitisbiologic failuredupilumabupadacitinib

Substanzen

Antibodies, Monoclonal, HumanizeddupilumabupadacitinibHeterocyclic Compounds, 3-Ring

Autor:innen und Institutionen

  • Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Dermatology Research Institute, Calgary, Alberta, Canada.
  • Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Dermatology Research Institute, Calgary, Alberta, Canada; Section of Community Pediatrics, Department of Pediatrics, Univ…
  • Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Division of…

Zitieren

APA

Georgakopoulos, J. R., Sheka, D., Rankin, B., Maliyar, K., Rimke, A., Prajapati, V. H., & Yeung, J. (2023). Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2023.08.059

Vancouver

Georgakopoulos JR, Sheka D, Rankin B, Maliyar K, Rimke A, Prajapati VH, et al. Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study. Journal of the American Academy of Dermatology. 2023. doi:10.1016/j.jaad.2023.08.059

BibTeX
@article{Georgakopoulos2023,
  author = {Georgakopoulos, Jorge R and Sheka, Dropen and Rankin, Brian and Maliyar, Khalad and Rimke, Alexander and Prajapati, Vimal H and Yeung, Jensen},
  title = {Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study},
  journal = {Journal of the American Academy of Dermatology},
  year = {2023},
  doi = {10.1016/j.jaad.2023.08.059}
}
Kostenlos starten →